- $7.20bn
- $7.95bn
- $2.05bn
- 91
- 15
- 96
- 75
2019 December 28th | R2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 938 | 1,144 | 2,036 | 1,239 | 2,048 |
Cost of Revenue | |||||
Gross Profit | 629 | 743 | 1,059 | 808 | 1,004 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 717 | 888 | 1,826 | 963 | 1,912 |
Operating Profit | 221 | 256 | 210 | 276 | 137 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 234 | 264 | 193 | 274 | 88.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 196 | 240 | 144 | 230 | 81.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 196 | 240 | 144 | 230 | 81.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 196 | 240 | 144 | 230 | 81.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.44 | 4.13 | 2.82 | 3.98 | 1.98 |
Dividends per Share |